BMS-538305 HCl, with the CAS number 841302-51-0, is a chemical compound that belongs to the class of small molecule inhibitors. It is primarily recognized for its role as a selective antagonist of certain receptors, particularly in the context of research related to neurological and psychiatric disorders. The hydrochloride salt form (HCl) enhances its solubility and stability, making it suitable for various pharmaceutical applications. BMS-538305 exhibits a specific mechanism of action that involves modulating neurotransmitter systems, which may contribute to its therapeutic potential. In terms of physical properties, it typically appears as a solid at room temperature and is soluble in polar solvents. Safety and handling precautions are essential, as with any chemical compound, to mitigate risks associated with exposure. Research involving BMS-538305 is ongoing, focusing on its efficacy and safety profile in clinical settings. As with all investigational compounds, comprehensive studies are necessary to fully understand its pharmacodynamics and pharmacokinetics.

BMS-538305 is a potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor.

BMS-538305 HCl

841302-51-0: BMS-538305 HCl, with the CAS number 841302-51-0, is a chemical compound that belongs to the class of small molecule inhibitors. It is primarily recognized for its role as a selective antagonist of certain receptors, particularly in the context of research related to neurological and psychiatric disorders. The hydrochloride salt form (HCl) enhances its solubility and stability, making it suitable for various pharmaceutical applications. BMS-538305 exhibits a specific mechanism of action that involves modulating neurotransmitter systems, which may contribute to its therapeutic potential. In terms of physical properties, it typically appears as a solid at room temperature and is soluble in polar solvents. Safety and handling precautions are essential, as with any chemical compound, to mitigate risks associated with exposure. Research involving BMS-538305 is ongoing, focusing on its efficacy and safety profile in clinical settings. As with all investigational compounds, comprehensive studies are necessary to fully understand its pharmacodynamics and pharmacokinetics.

BMS-538305 is a potent, selective inhibitor of dipeptidyl peptidase IV (DPP-IV).

CAS 841302-51-0

BMS-538305 HCl

BMS-538305 HCl

Ref: TM-T26850